Terns Pharmaceuticals, Inc.
TERN
$52.63
$0.070.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.57M | -24.64M | -24.09M | -23.91M | -21.80M |
| Total Depreciation and Amortization | 113.00K | 111.00K | 108.00K | 169.00K | 214.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.83M | 3.39M | 3.04M | 3.60M | 2.74M |
| Change in Net Operating Assets | 548.00K | 1.37M | 2.07M | -4.30M | 4.26M |
| Cash from Operations | -19.08M | -19.77M | -18.88M | -24.44M | -14.58M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -350.00M | 24.50M | 25.50M | 1.96M | -94.35M |
| Cash from Investing | -350.00M | 24.50M | 25.50M | 1.96M | -94.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 743.35M | 0.00 | 324.00K | 74.00K | 617.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -229.00K | 0.00 | 0.00 | -6.00K | -313.00K |
| Cash from Financing | 743.12M | 0.00 | 324.00K | 68.00K | 304.00K |
| Foreign Exchange rate Adjustments | 15.00K | 5.00K | -1.00K | -3.00K | -69.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 374.05M | 4.73M | 6.94M | -22.42M | -108.70M |